XOMA GAAP EPS of $0.70 beats by $0.74, revenue of $9.35M misses by $2.12M [Seeking Alpha]
LAVA Therapeutics N.V. - Ordinary Shares (LVTX)
Company Research
Source: Seeking Alpha
XOMA Royalty PFD Update: Going Back To My Original Sell Ratings XOMA extends tender offer for LAVA Therapeutics to Oct 17 Mural Oncology to be acquired by XOMA unit for up to $2.24/share in cash Seeking Alpha's Quant Rating on XOMA Historical earnings data for XOMA Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
LVTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LVTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LVTX alerts
High impacting LAVA Therapeutics N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
LVTX
News
- LAVA intents to delist from Nasdaq [Seeking Alpha]Seeking Alpha
- LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from NasdaqGlobeNewswire
- XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements [Yahoo! Finance]Yahoo! Finance
- LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline [Yahoo! Finance]Yahoo! Finance
- LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 DeadlineGlobeNewswire
LVTX
Earnings
- 3/28/25 - Beat
LVTX
Sec Filings
- 11/21/25 - Form 25-NSE/A
- 11/21/25 - Form S-8
- 11/21/25 - Form S-8
- LVTX's page on the SEC website